Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 16, 2022 14:28 UTC |
DALY RICHARD JDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 4,117 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002261 · doc4.xml · derivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,117 Underlying: Common Stock · 4,117 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:29 UTC |
Tae Michael SCorporate VP, CTO, ICS
|
GrantStock Option (Right to Buy) · Derivative | 6,862 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002272 · doc4.xml · derivative · entry 2 Tae Michael S · CIK 0001663476 · Corporate VP, CTO, ICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,312 Underlying: Common Stock · 6,862 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:29 UTC |
Tae Michael SCorporate VP, CTO, ICS
|
GrantStock Option (Right to Buy) · Derivative | 27,450 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002272 · doc4.xml · derivative · entry 1 Tae Michael S · CIK 0001663476 · Corporate VP, CTO, ICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,450 Underlying: Common Stock · 27,450 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:29 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantStock Option (Right to Buy) · Derivative | 8,235 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002271 · doc4.xml · derivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,235 Underlying: Common Stock · 8,235 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:29 UTC |
Reese EdmundCorporate VP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 24,018 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002269 · doc4.xml · derivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,018 Underlying: Common Stock · 24,018 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:28 UTC |
Carey Thomas PCorporate VP
|
GrantStock Option (Right to Buy) · Derivative | 14,068 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002260 · doc4.xml · derivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,068 Underlying: Common Stock · 14,068 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:29 UTC |
PERRY CHRISTOPHER JOHNPresident
|
GrantStock Option (Right to Buy) · Derivative | 30,195 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002268 · doc4.xml · derivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,195 Underlying: Common Stock · 30,195 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:29 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,607 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002264 · doc4.xml · derivative · entry 1 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,607 Underlying: Common Stock · 16,607 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:28 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
GrantStock Option (Right to Buy) · Derivative | 6,313 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002262 · doc4.xml · derivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,313 Underlying: Common Stock · 6,313 shares Expires 2032-02-14 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 19:28 UTC |
KALENKA ROBERT FCorporate Vice President
|
GrantStock Option (Right to Buy) · Derivative | 6,107 | $0.00 Strike: $144.84 | $0.00 |
DisclosureSEC source: 0001225208-22-002259 · doc4.xml · derivative · entry 2 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,107 Underlying: Common Stock · 6,107 shares Expires 2032-02-14 F2 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 14, 2023. Read SEC document |
| February 04, 2022 Filed Feb 16, 2022 19:28 UTC |
KALENKA ROBERT FCorporate Vice President
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002259 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,355.4097 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 16:55 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,943 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001272 · doc4.xml · derivative · entry 6 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,721 Underlying: Common Stock · 1,943 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 16:55 UTC |
Reese EdmundCorporate VP and CFO
|
Tax withholdingCommon Stock | 1,075 | $153.33 | $164,829.75 |
DisclosureSEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 4 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,912 Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 16:55 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionCommon Stock | 1,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 3 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on February 1, 2022 1,943 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 16:55 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,021 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001272 · doc4.xml · derivative · entry 5 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,664 Underlying: Common Stock · 3,021 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 16:55 UTC |
Reese EdmundCorporate VP and CFO
|
Tax withholdingCommon Stock | 1,700 | $159.22 | $270,674.00 |
DisclosureSEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 2 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,044 Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 16:55 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionCommon Stock | 3,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001272 · doc4.xml · nonDerivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on January 31, 2022 3,021 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| January 10, 2022 Filed Aug 15, 2022 22:20 UTC |
Reese EdmundCorporate VP and CFO
|
GrantCommon Stock | 6.39 | $174.33 | $1,113.97 |
DisclosureSEC source: 0001225208-22-009544 · doc5.xml · nonDerivative · entry 3 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,742.21 F1 · shares: Represents shares of Broadridge common stock acquired through dividend reinvestment during the fiscal year. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000577 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,302 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 12:26 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000582 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,170 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000578 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
keller brettDirector
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000579 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,950 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
keller brettDirector
|
GrantCommon Stock | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000579 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,945 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 12:25 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000575 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,493 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000583 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,654 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000583 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,648 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000581 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 648 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000580 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,919.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000580 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,909.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:26 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000576 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,314 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| December 28, 2021 Filed Dec 28, 2021 21:49 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 466 | $0.00 Strike: $98.31 | $0.00 |
DisclosureSEC source: 0001225208-21-015251 · doc4.xml · derivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,239 Underlying: Common Stock · 466 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 11, 2021. Read SEC document |
| December 28, 2021 Filed Dec 28, 2021 21:49 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 415 | $185.04 | $76,791.02 |
DisclosureSEC source: 0001225208-21-015251 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,639.528 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 - $185.08, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| December 28, 2021 Filed Dec 28, 2021 21:49 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 466 | $98.31 | $45,812.46 |
DisclosureSEC source: 0001225208-21-015251 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,054.528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 11, 2021. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:22 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,079 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-015089 · doc4.xml · derivative · entry 3 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,057 Underlying: Common Stock · 8,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:22 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 3,886 | $178.02 | $691,785.72 |
DisclosureSEC source: 0001225208-21-015089 · doc4.xml · nonDerivative · entry 2 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,193 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 16:22 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
Exercise / conversionCommon Stock | 8,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-015089 · doc4.xml · nonDerivative · entry 1 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on December 15, 2021 8,079 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 17:20 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,040 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001225208-21-014551 · doc4.xml · derivative · entry 4 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,611 Underlying: Common Stock · 18,040 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 17:20 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 15,063 | $173.26 | $2,609,830.44 |
DisclosureSEC source: 0001225208-21-014551 · doc4.xml · nonDerivative · entry 3 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,604.6729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 - $174.17, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 17:20 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 3,000 | $173.26 | $519,783.00 |
DisclosureSEC source: 0001225208-21-014551 · doc4.xml · nonDerivative · entry 2 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,667.6729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 - $174.17, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 17:20 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 18,040 | $50.95 | $919,138.00 |
DisclosureSEC source: 0001225208-21-014551 · doc4.xml · nonDerivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,667.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 17:00 UTC |
keller brettDirector
|
GrantCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014545 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,923 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 17:00 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 153 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014548 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,641 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 17:00 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014547 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 17:00 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014546 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,868.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:19 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,960 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001225208-21-014505 · doc4.xml · derivative · entry 3 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,651 Underlying: Common Stock · 14,960 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:19 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
SaleCommon Stock | 12,488 | $173.11 | $2,161,758.97 |
DisclosureSEC source: 0001225208-21-014505 · doc4.xml · nonDerivative · entry 2 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,627.6729 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.00 - $173.9150, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:19 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 14,960 | $50.95 | $762,212.00 |
DisclosureSEC source: 0001225208-21-014505 · doc4.xml · nonDerivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,115.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Nov 29, 2021 14:48 UTC |
Mayadas VijayCorporate Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,029 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-21-014173 · doc4.xml · derivative · entry 18 Mayadas Vijay · CIK 0001658677 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,343 Underlying: Common Stock · 4,029 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Nov 29, 2021 14:48 UTC |
Mayadas VijayCorporate Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,604 | $0.00 Strike: $98.31 | $0.00 |
DisclosureSEC source: 0001225208-21-014173 · doc4.xml · derivative · entry 17 Mayadas Vijay · CIK 0001658677 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,604 Underlying: Common Stock · 3,604 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2021 Filed Nov 29, 2021 14:48 UTC |
Mayadas VijayCorporate Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,299 | $0.00 Strike: $67.32 | $0.00 |
DisclosureSEC source: 0001225208-21-014173 · doc4.xml · derivative · entry 16 Mayadas Vijay · CIK 0001658677 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,299 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.